Most Recent
A decision on the fate of three class actions against logistics software company GetSwift is set for Wednesday, and counsel behind the competing cases aren't the only lawyers waiting with baited breath.
A full bench of the Federal Court has dismissed an appeal by drug giant GlaxoSmithKline in a patent infringement case it brought over planned generic versions of its sustained-release Panadol.
Branhaven will seek court approval to amend the bovine gene patent held by it and Cargill, after the Federal Court sided with a challenge by Meat & Livestock Australia and found the patent was invalid.
Lawyers running a class action against Murray Goulburn want access to evidence that the dairy cooperative's trust consulted with a QC about possible claims against its law firm, Herbert Smith Freehills.
The judge who sided with Medibank in the ACCC's failed case last year paid little attention to one of the consumer regulator's central arguments against the private health insurer, a court heard Monday.
A federal court judge has found that a bovine gene patent held by Cargill Inc. is invalid, but said the American agriculture giant could beef up the patent claims in response to his ruling.
The trial against three of Australia's biggest banks over alleged interest rate rigging was pushed back again on Wednesday after lawyers for National Australia Bank and Australia and New Zealand Banking Group told the Federal Court they were still in settlement talks with the securities regulator.